Published in Gut on May 01, 1977
Treatment of hepatic encephalopathy with metronidazole. Gut (1982) 1.61
Intestinal pseudo-obstruction--a review. Postgrad Med J (1985) 1.02
Antibiotic susceptibility testing by a standardized single disk method. Am J Clin Pathol (1966) 159.00
Susceptibility of anaerobic bacteria to metronidazole: relative resistance of non-spore-forming gram-positive baccilli. J Infect Dis (1975) 3.11
Jejunal diverticulosis; some clinical aspects. Br J Surg (1953) 1.78
Jejunoileal bypass for massive obesity: results and complications in fifty-two patients. Ann Surg (1974) 1.64
Colonic pseudo-obstruction: a new complication of jejunoileal bypass. Gut (1975) 1.15
Molecular typing of Staphylococcus aureus on the basis of coagulase gene polymorphisms. J Clin Microbiol (1992) 4.13
Canadian guidelines for the initial management of community-acquired pneumonia: an evidence-based update by the Canadian Infectious Diseases Society and the Canadian Thoracic Society. The Canadian Community-Acquired Pneumonia Working Group. Clin Infect Dis (2000) 4.01
A single clone of Staphylococcus aureus causes the majority of cases of toxic shock syndrome. Proc Natl Acad Sci U S A (1990) 3.76
Management of anaerobic infections. Ann Intern Med (1975) 3.62
Susceptibility of anaerobic bacteria to metronidazole: relative resistance of non-spore-forming gram-positive baccilli. J Infect Dis (1975) 3.11
HSP60 gene sequences as universal targets for microbial species identification: studies with coagulase-negative staphylococci. J Clin Microbiol (1996) 3.03
Serious infections in adults due to group B streptococci. Clinical and serotypic characterization. Am J Med (1976) 2.58
Endocervical Neisseria meningitidis with meningococcemia. N Engl J Med (1971) 2.51
Lactobacillemia--report of nine cases. Important clinical and therapeutic considerations. Am J Med (1978) 2.46
Bacteroidaceae bacteremia: clinical experience with 112 patients. Medicine (Baltimore) (1974) 2.21
Susceptibility of Campylobacter fetus to twenty-two antimicrobial agents. Antimicrob Agents Chemother (1978) 2.13
Anorectal gonococcal infection. Ann Intern Med (1977) 1.96
Coeliac disease. The clinical presentation. Clin Gastroenterol (1974) 1.89
The lack of therapeutic effect of Saccharomyces boulardii in the prevention of antibiotic-related diarrhoea in elderly patients. J Infect (1998) 1.88
High-density substrate mapping in Brugada syndrome: combined role of conduction and repolarization heterogeneities in arrhythmogenesis. Circulation (2009) 1.83
Combined use of gentamicin and carbenicillin. Ann Intern Med (1971) 1.81
Detection of continuing gluten ingestion in treated coeliac patients. Br Med J (1975) 1.76
Gardnerella vaginalis has a gram-positive cell-wall ultrastructure and lacks classical cell-wall lipopolysaccharide. J Med Microbiol (1989) 1.75
Species identification and phylogenetic relationships based on partial HSP60 gene sequences within the genus Staphylococcus. Int J Syst Bacteriol (1999) 1.75
Susceptibility of herpesviruses to three nucleoside analogues and their combinations and enhancement of the antiviral effect of acid pH. J Infect Dis (1974) 1.74
Comparative in vitro activity of newer cephalosporins against anaerobic bacteria. Antimicrob Agents Chemother (1978) 1.72
Recurrent leukaemoid reaction in pernicious anaemia complicated by gastric carcinoma. Br Med J (1969) 1.71
Comparative susceptibility of anaerobic bacteria to ticarcillin, cefoxitin, metronidazole, and related antimicrobial agents. Antimicrob Agents Chemother (1977) 1.67
Orofacial odontogenic infections. Ann Intern Med (1978) 1.67
Coeliac disease and malignancy. Q J Med (1973) 1.62
Clinical spectrum of nonmenstrual toxic shock syndrome (TSS): comparison with menstrual TSS by multivariate discriminant analyses. Clin Infect Dis (1993) 1.60
Comparative susceptibility of anaerobic bacteria to minocycline, doxycycline, and tetracycline. Antimicrob Agents Chemother (1975) 1.59
Erythromycin. Med Clin North Am (1982) 1.58
Cephalothin and cephaloridine therapy for bacterial meningitis. Ann Intern Med (1975) 1.58
Necrotizing pneumonia and empyema due to Clostridium perfringens. Report of a case and review of the literature. Am J Med (1975) 1.56
Role of anaerobic bacteria in spontaneous peritonitis of cirrhosis: report of two cases and review of the literature. Am J Med (1977) 1.53
Non-Hodgkin's lymphoma, coeliac disease, and Epstein-Barr virus: a study of 13 cases of enteropathy-associated T- and B-cell lymphoma. J Pathol (1995) 1.49
Gluten-induced mucosal changes in subjects without overt small-bowel disease. Lancet (1981) 1.48
Adoption of guidelines for Universal Precautions and Body Substance Isolation in Canadian acute-care hospitals. Infect Control Hosp Epidemiol (1990) 1.47
The bacteriology of acute pelvic inflammatory disease. Am J Obstet Gynecol (1975) 1.46
Sepsis associated with decubitus ulcers. Am J Med (1976) 1.44
Comparative in vitro activity of ceftizoxime, cefoperazone, and cefoxitin against anaerobic bacteria. Antimicrob Agents Chemother (1981) 1.40
Gut is not a source of cytokines in a porcine model of endotoxicosis. Surgery (1996) 1.40
Role of anaerobic bacteria in subdural empyema. Report of four cases and review of 327 cases from the English literature. Am J Med (1975) 1.39
Use and safety of antimicrobial agents during pregnancy. West J Med (1987) 1.38
Prenatal laboratory screening. Tex Med (1990) 1.36
Pharmacokinetics and safety of antimicrobial agents during pregnancy. Rev Infect Dis (1985) 1.33
Prospective randomized trial of piperacillin monotherapy versus carboxypenicillin-aminoglycoside combination regimens in the empirical treatment of serious bacterial infections. Antimicrob Agents Chemother (1983) 1.29
Neonatal scalp abscess following intrapartum fetal monitoring: prospective comparison of two spiral electrodes. Am J Obstet Gynecol (1977) 1.29
The significance of anaerobes in neonatal bacteremia: analysis of 23 cases and review of the literature. Pediatrics (1974) 1.28
Efficacy of microbial identification system for epidemiologic typing of coagulase-negative staphylococci. J Clin Microbiol (1994) 1.26
Individual and group hypnotherapy in treatment of refractory irritable bowel syndrome. Lancet (1989) 1.26
Primary meningococcal pericarditis presenting with tamponade. Chest (1975) 1.25
Susceptibility of 40 lactobacilli to six antimicrobial agents with broad gram-positive anaerobic spectra. Antimicrob Agents Chemother (1978) 1.24
Serum amyloid A protein compared with C-reactive protein, alpha 1-antichymotrypsin and alpha 1-acid glycoprotein as a monitor of inflammatory bowel disease. Eur J Clin Invest (1987) 1.24
Parenteral clindamycin therapy for severe anaerobic infections. Arch Intern Med (1974) 1.23
Colony immunoblot assay for the detection of staphylococcal toxic shock syndrome toxin 1 (TSST-1) with anti-TSST-1 F(ab')2 fragments. J Clin Microbiol (1989) 1.23
A nosocomial outbreak of infections due to multiply resistant Proteus mirabilis: role of intestinal colonization as a major reservoir. J Infect Dis (1979) 1.20
Cytosine arabinoside therapy for herpes simplex encephalitis--clinical experience with six patients. Antimicrob Agents Chemother (1973) 1.20
Spontaneous peritonitis of cirrhosis due to Campylobacter fetus. Gastroenterology (1976) 1.19
Experience with jejunoileal bypass for obesity. Surg Gynecol Obstet (1976) 1.18
Survival of anaerobic and aerobic bacteria in a nonsupportive gassed transport system. J Clin Microbiol (1976) 1.18
Adult bacteremic Haemophilus parainfluenzae infections. Seven reports of cases and a review of the literature. Arch Intern Med (1979) 1.17
Subgaleal abscess: a preventable complication of scalp trauma. West J Med (1977) 1.17
Colonic pseudo-obstruction: a new complication of jejunoileal bypass. Gut (1975) 1.15
Fluorescein dilaurate--tubeless test for pancreatic exocrine failure. Lancet (1982) 1.14
Detection and quantitation of toxic shock syndrome toxin 1 in vitro and in vivo by noncompetitive enzyme-linked immunosorbent assay. J Clin Microbiol (1987) 1.11
Induction of tumor necrosis factor and interleukin-1 by purified staphylococcal toxic shock syndrome toxin 1 requires the presence of both monocytes and T lymphocytes. Infect Immun (1992) 1.11
Neonatal scalp abscess and fetal monitoring: factors associated with infection. Am J Obstet Gynecol (1977) 1.10
Rapid screening of Veillonella by ultraviolet fluorescence. J Clin Microbiol (1975) 1.08
Anaerobic infections of the female genital tract: prospects and perspectives. Obstet Gynecol Surv (1975) 1.08
Epidemiologic typing systems for coagulase-negative staphylococci. Infect Control Hosp Epidemiol (1991) 1.06
Intestinal adaptation after jejunoileal bypass in man. Am J Clin Nutr (1977) 1.04
Detection of staphylococcal enterotoxin B among toxic shock syndrome (TSS)- and non-TSS-associated Staphylococcus aureus isolates. J Infect Dis (1992) 1.04
Characterization of the hemolytic activity of Staphylococcus aureus strains associated with toxic shock syndrome. J Clin Microbiol (1983) 1.03
Bactericidal synergy between penicillin or ampicillin and aminoglycosides against antibiotic-tolerant lactobacilli. Antimicrob Agents Chemother (1980) 1.03
Case report. Haemophilus parainfluenzae epiglottitis with meningitis and bacteremia in an adult. Am J Med Sci (1974) 1.02
Intestinal bypass surgery for obesity decreases food intake and taste preferences. Am J Clin Nutr (1976) 1.01
A case of small-intestinal mucosal atrophy. Gut (1970) 1.01
Cytosine arabinoside therapy for herpesvirus infections. Antimicrob Agents Chemother (Bethesda) (1970) 1.01
Microbiology of toxic shock syndrome: overview. Rev Infect Dis (1989) 1.01
An in vivo comparison of two bile salt binding agents, cholestyramine and lignin. Scand J Gastroenterol (1971) 1.00
Staphylococcal toxic shock syndrome toxin 1-induced tumor necrosis factor alpha and interleukin-1 beta secretion by human peripheral blood monocytes and T lymphocytes is differentially suppressed by protein kinase inhibitors. Infect Immun (1992) 1.00
In-vitro activity of ceftizoxime against anaerobic bacteria and comparison with other cephalosporins. J Antimicrob Chemother (1982) 1.00
Recombinant interferon-alpha in inoperable hepatocellular carcinoma: a randomized controlled trial. Hepatology (1993) 0.99
Interactions of ciprofloxacin with clindamycin, metronidazole, cefoxitin, cefotaxime, and mezlocillin against gram-positive and gram-negative anaerobic bacteria. Antimicrob Agents Chemother (1987) 0.99
Regulation of helper T cell responses to staphylococcal superantigens. Eur Cytokine Netw (2001) 0.99
Summary of Canadian guidelines for the initial management of community-acquired pneumonia: an evidence-based update by the Canadian Infectious Disease Society and the Canadian Thoracic Society. Can Respir J (2000) 0.98
Vaginal colonization with Staphylococcus aureus, positive for toxic-shock marker protein, and Escherichia coli in healthy women. J Infect Dis (1984) 0.98
Physician's use of laparoscopy. Br Med J (1978) 0.98
Variant postpartum toxic shock syndrome with probable intrapartum transmission to the neonate. Am J Obstet Gynecol (1984) 0.96
Inhibition of staphylococcal enterotoxin B-induced lymphocyte proliferation and tumor necrosis factor alpha secretion by MAb5, an anti-toxic shock syndrome toxin 1 monoclonal antibody. Infect Immun (2000) 0.95
Sternoarticular septic arthritis in heroin users. N Engl J Med (1973) 0.95
Gram-negative bacillary septic arthritis: clinical, radiographic, therapeutic, and prognostic features. Semin Arthritis Rheum (1977) 0.95
Comparative in vitro activity of five cephalosporins against Lactobacilli. Antimicrob Agents Chemother (1979) 0.95
Listeria monocytogenes endocarditis: report of a case and review of the literature. Am J Med Sci (1977) 0.95
Acetaldehyde alone may initiate hepatocellular damage in acute alcoholic liver disease. Gut (1985) 0.94
Primary yolk sac tumour of the liver in adulthood. J Clin Pathol (1998) 0.94
The human vagina: normal flora considered as an in situ tissue-associated, adherent biofilm. Genitourin Med (1991) 0.94
Surgical treatment of obesity: a review of our experience and an analysis of published reports. Int J Obes (1977) 0.93
Comparison of susceptibility of gentamicin-resistant and -susceptible "Acinetobacter anitratus" to 15 alternative antibiotics. Antimicrob Agents Chemother (1986) 0.93
Toxic shock syndrome in the postoperative patient. Surg Gynecol Obstet (1982) 0.92
Acetaldehyde binds to liver cell membranes without affecting membrane function. Gut (1984) 0.92
Randomized, double-blind, multicenter trial comparing clinafloxacin with imipenem as empirical monotherapy for febrile granulocytopenic patients. Clin Infect Dis (2001) 0.92